Benzinga | Sep 27, 2021 07:40AM EDT

Soligenix Invited To Present At The Cantor Fitzgerald Global Healthcare Conference

Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will participate in a fireside chat hosted by Kristen Kluska, Director, Equity Research, at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 29, 2021 at 8:00AM ET. In addition to the fireside chat, Dr. Schaber will be available to participate in virtual one-on-one meetings with those who are registered to attend. A webcast of the live fireside chat will be available following the event, please visit https://wsw.com/webcast/cantor12/sngx/2112320.

For more information about the Cantor Fitzgerald Global Healthcare Conference, please refer to the conference website at https://www.cantor.com/global-healthcare-2021/.

For further information regarding Soligenix, Inc., please visit the Company's website at www.soligenix.com.